GGrantIndex
Sort

35,931 grants matching parkinsons

Direct CNS Delivery System for BDNF AntagoNATs using Heterotopic Mucosal Grafting for the Treatment of Parkinson's Disease

$504,376
Benjamin Bleier · Massachusetts Eye And Ear Infirmary · R01 · FY2022 · NS

Neuronal quality control and neuroprotection in tauopathies

$504,368
Charleen T Chu · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AG

Neuronal quality control and neuroprotection in tauopathies

$504,368
Charleen T Chu · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AG

IMPACT OF CHRONIC GDNF ON RECOVERY FROM 6-OHDA

$504,176
Children'S Memorial Hospital (Chicago) · R01 · FY2003 · NS

Neuronal Activity in MC and SMA during STN and GPi DBS in the Parkinsonian Monkey

$504,169
Jerrold L Vitek · University Of Minnesota · R01 · FY2013 · NS

Proteolytic and chaperone machines implicated in virulence and disease

$504,147
Robert T Sauer · Massachusetts Institute Of Technology · R01 · FY2016 · AI

Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors

$504,105
Justin S. Hanes · Johns Hopkins University · R01 · FY2020 · CA

Time and Spatially Resolved Fiber Diffraction pp.505-568

$503,975
Thomas C Irving · Illinois Institute Of Technology · P41 · FY2016 · GM

Clinical Coordinating Center for the Acute to Chronic Pain Signatures Program

$503,908
Kathleen A Sluka · University Of Iowa · U24 · FY2022 · NS

Segmenting Brain Structures for Neurological Disorders

$503,867
Bruce Fischl · Massachusetts General Hospital · R01 · FY2021 · NS

Function and Pathogenic Mechanism of LRRK2 in Parkinson's Disease

$503,811
Huaibin Cai · National Institute On Aging · ZIA · FY2014 · AG

The Function of Synuclein

$503,521
Robert H Edwards · University Of California, San Francisco · R01 · FY2022 · NS

The Function of Synuclein

$503,521
Robert H Edwards · University Of California, San Francisco · R01 · FY2021 · NS

The Function of Synuclein

$503,521
Robert H Edwards · University Of California, San Francisco · R01 · FY2023 · NS

Effects of a null mutation of the tumor suppressor gene PTEN in dopamine neurons

$503,400
Barry Hoffer · National Institute On Drug Abuse · ZIA · FY2011 · DA

Resource Core II: In Vivo Core

$503,215
Victor Steven Van Laar · University Of California Berkeley · U19 · FY2024 · NS

Innovative systemic gene therapy for treating Parkinson's disease

$502,994
Jung Soo Suk · Johns Hopkins University · R01 · FY2022 · NS

Minocycline to Improve Neurologic Outcome (MINO Clinical Trial)

$502,980
David C Hess · Augusta University · R01 · FY2008 · NS

Effect of Agent and Host Factors on Alpha-Synuclein Strain Pathogenesis

$502,835
Amanda L. Woerman · Colorado State University · R01 · FY2024 · NS

Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry

$502,750
Thomas J Montine · University Of Washington · U19 · FY2020 · AG

Dynamics of Olfactory Processing: Segmentation in the Piriform Cortex

$502,742
Kevin Franks · Duke University · R01 · FY2025 · DC

Propagation of Lipid-Anchored Prion Aggregates

$502,699
Gerald Baron · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Selective inhibition of nitric oxide synthase for multiple indications

$502,671
Richard B Silverman · Northwestern University · R01 · FY2015 · GM

Molecular Imaging of Biomaterials - signal Cells

$502,630
Pennsylvania State University-Univ Park · R01 · FY2005 · EB

Epidemilogy of Parkinsonism in Welders

$502,477
Brad A Racette · Washington University · R01 · FY2011 · ES